Skip to main content Back to Top
Advertisement

7/14/2020

Mupirocin Calcium 2% Nasal Ointment

Products Affected - Description

    • Bactroban 2% nasal ointment, GlaxoSmithKline, 1 gram tube, 10 count, NDC 00029-1526-11 - discontinued

Reason for the Shortage

    • GlaxoSmithKline discontinued Bactroban 2% nasal ointment in June 2020.[1]

Available Products

    • There are no presentations available.

Alternative Agents & Management

    • As an alternative to single-use tubes, 500 mg from a 22 gram tube can be applied into each nostril using a cotton swab.[3]

References

    1. GlaxoSmithKline (personal communications). August 5, November 7, 2016; January 27, February 14, May 22, July 28, November 3, 2017; January 10, April 17, July 25, October 23, December 5, 2018; March 12, April 5, July 9, September 24, November 20, 2019; January 14, April 16, and July 14, 2020.
    2. GlaxoSmithKline. Bactroban Nasal (mupirocin calcium) ointment 2% [product labeling]. Research Triangle Park, NC: GlaxoSmithKline; 2015
    3. Mupirocin. Lexi-Drugs Online. Hudson, OH: Lexi-Comp, Inc.; 2020.

Updated

Updated July 14, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 13, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.